Nick Wooding

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher Butler, Richard Hobbs, Oghenekome Gbinigie et al. · The Lancet · 2022 · 406 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

Rebecca C. Fitzgerald, Massimiliano di Pietro, Maria O’Donovan et al. · The Lancet · 2020 · 253 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Circumstances of child deaths in Mali and Uganda: a community-based confidential enquiry

Merlin Willcox, Elias Kumbakumba, Drissa Diallo et al. · The Lancet Global Health · 2018 · 55 citations · Full text

Public Health, Child Health, Community Health +17

Reach and Cost-Effectiveness of the PrePex Device for Safe Male Circumcision in Uganda

Kevin Duffy, Moses Galukande, Nick Wooding et al. · PLoS ONE · 2013 · 34 citations · Full text

Pharmacy, Health Sciences, Surgery +13